Stay updated on Tideglusib in Congenital Myotonic Dystrophy Clinical Trial
Sign up to get notified when there's something new on the Tideglusib in Congenital Myotonic Dystrophy Clinical Trial page.

Latest updates to the Tideglusib in Congenital Myotonic Dystrophy Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedUpdates to date-related content: new dates added and older dates removed, shifting the time window forward.SummaryDifference0.5%

- Check27 days agoChange DetectedUpdated version to v3.2.0, added government operating-status notices and a new topic (Myotonic dystrophy); removed the old revision note v3.1.0.SummaryDifference3%

- Check34 days agoChange DetectedAdd: Steinert myotonic dystrophy syndrome; Revision updated to v3.1.0. Remove: older topics and revision v3.0.2.SummaryDifference0.8%

- Check48 days agoChange DetectedThe page now shows expanded access and posted results, plus a full suite of clinician- and caregiver-rated outcome measures through week 20 with independent ratings, while older endpoints like 22-week data and certain walk/run tests have been removed.SummaryDifference34%

- Check55 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check63 days agoChange DetectedThe web page has undergone significant updates, including the addition of new resources related to genetic diseases and drug safety, while removing previous references to certain locations and genetic conditions.SummaryDifference3%

Stay in the know with updates to Tideglusib in Congenital Myotonic Dystrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tideglusib in Congenital Myotonic Dystrophy Clinical Trial page.